ACUT
Price:
$0.3101
Market Cap:
$0
AccuStem Sciences, Inc. operates as a life sciences company focusing on improving outcomes for patients with cancer. It develops StemPrintER technology, a multi-gene prognostic assay to predict the risk of recurrence of Endocrine receptor-positive /HER2- breast cancer; and Spare, a derivative of StemPrintER that combines StemPrintER with two clinical markers. The company is based in New York, New York.[Read more]
Industry
Biotechnology
IPO Date
2022-03-03
Stock Exchange
PNK
Ticker
ACUT
According to Accustem Sciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is -71010.00. This represents a change of -105.71% compared to the average of 1.24M of the last 4 quarters.
The mean historical Enterprise Value of Accustem Sciences Inc. over the last ten years is 1.18M. The current -71010.00 Enterprise Value has changed -703.55% with respect to the historical average. Over the past ten years (40 quarters), ACUT's Enterprise Value was at its highest in in the September 2023 quarter at 1.46M. The Enterprise Value was at its lowest in in the March 2022 quarter at -1890703.22.
Average
1.18M
Median
1.18M
Minimum
753.20K
Maximum
1.60M
Discovering the peaks and valleys of Accustem Sciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Enterprise Value = 1.60M
Minimum Annual Increase = -52.92%
Minimum Annual Enterprise Value = 753.20K
Year | Enterprise Value | Change |
---|---|---|
2022 | 753.20K | -52.92% |
The current Enterprise Value of Accustem Sciences Inc. (ACUT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
1.18M
5-year avg
1.18M
10-year avg
1.18M
Accustem Sciences Inc.’s Enterprise Value is less than Tiziana Life Sciences Ltd (94.67M), less than Avacta Group Plc (183.03M), less than Acurx Pharmaceuticals, Inc. (23.69M), less than Alpha Cognition Inc. (58.12M), less than Aadi Bioscience, Inc. (8.16M),
Company | Enterprise Value | Market cap |
---|---|---|
94.67M | $95.60M | |
183.03M | $190.26M | |
23.69M | $30.05M | |
58.12M | $57.93M | |
8.16M | $48.25M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Accustem Sciences Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Accustem Sciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Accustem Sciences Inc.'s Enterprise Value?
What is the highest Enterprise Value for Accustem Sciences Inc. (ACUT)?
What is the 3-year average Enterprise Value for Accustem Sciences Inc. (ACUT)?
What is the 5-year average Enterprise Value for Accustem Sciences Inc. (ACUT)?
How does the current Enterprise Value for Accustem Sciences Inc. (ACUT) compare to its historical average?